Renovación del mercado de abastos de Tumán a través de un edificio de usos mixtos: Una propuesta para la mejora funcional

El presente estudio se enfoca en resolver los problemas del Mercado de Abastos de Tumán a través de una propuesta que implica el diseño de un edificio de usos variados, incluyendo comerciales e informales, así mismo incluyendo actividades no cotidianas en un mercado, con el propósito de revitalizar tanto el funcionamiento del mercado como el entorno urbano circundante. La investigación se llevó a cabo empleando un enfoque descriptivo, con el objetivo de ofrecer una solución innovadora, se establecieron metas específicas. En primer lugar, se realizó un diagnóstico del estado físico actual del mercado, evaluando su cumplimiento con las regulaciones vigentes. En segundo lugar, se identificaron las actividades comerciales existentes en la ciudad de Tumán con el fin de incorporarlas en la nueva infraestructura. Además, se llevó a cabo un análisis y estudio de proyectos arquitectónicos similares a edificios de usos mixtos, que han abordado desafíos análogos en mercados minoristas urbanos. El propósito fundamental de este estudio es mejorar el entorno arquitectónico del Mercado de Abastos de Tumán, promoviendo la creación de un espacio saludable y fomentando el bienestar general de la comunidad. La meta es desarrollar una infraestructura óptima, segura y diversificada, que ofrezca una experiencia diferente a la de un mercado tradicional y fomente la interacción entre la comunidad y su entorno urbano. En resumen, esta investigación plantea una solución innovadora y sostenible para abordar la disfuncionalidad del Mercado de Abastos de Tumán con el objetivo de impulsar elEl presente estudio se enfoca en resolver los problemas del Mercado de Abastos de Tumán a través de una propuesta que implica el diseño de un edificio de usos variados, incluyendo comerciales e informales, así mismo incluyendo actividades no cotidianas en un mercado, con el propósito de revitalizar tanto el funcionamiento del mercado como el entorno urbano circundante. La investigación se llevó a cabo empleando un enfoque descriptivo, con el objetivo de ofrecer una solución innovadora, se establecieron metas específicas. En primer lugar, se realizó un diagnóstico del estado físico actual del mercado, evaluando su cumplimiento con las regulaciones vigentes. En segundo lugar, se identificaron las actividades comerciales existentes en la ciudad de Tumán con el fin de incorporarlas en la nueva infraestructura. Además, se llevó a cabo un análisis y estudio de proyectos arquitectónicos similares a edificios de usos mixtos, que han abordado desafíos análogos en mercados minoristas urbanos. El propósito fundamental de este estudio es mejorar el entorno arquitectónico del Mercado de Abastos de Tumán, promoviendo la creación de un espacio saludable y fomentando el bienestar general de la comunidad. La meta es desarrollar una infraestructura óptima, segura y diversificada, que ofrezca una experiencia diferente a la de un mercado tradicional y fomente la interacción entre la comunidad y su entorno urbano. En resumen, esta investigación plantea una solución innovadora y sostenible para abordar la disfuncionalidad del Mercado de Abastos de Tumán con el objetivo de impulsar el progreso y el desarrollo integral de la ciudad.The present study focuses on solving the problems of the Tumán Food Market through a proposal that involves the design of a building for varied uses, including commercial and informal, as well as including non-daily activities in a market, with the purpose of revitalize both the functioning of the market and the surrounding urban environment. The research was carried out using a descriptive approach, with the aim of offering an innovative solution, specific goals were established. Firstly, a diagnosis of the current physical state of the market was carried out, evaluating its compliance with current regulations. Secondly, the existing commercial activities in the city of Tumán were identified in order to incorporate them into the new infrastructure. Additionally, an analysis and study was carried out on architectural projects similar to mixed-use buildings, which have addressed analogous challenges in urban retail markets. The fundamental purpose of this study is to improve the architectural environment of the Tumán Food Market, promoting the creation of a healthy space and promoting the general well-being of the community. The goal is to develop an optimal, safe and diversified infrastructure, which offers a different experience from that of a traditional market and encourages interaction between the community and its urban environment. In summary, this research proposes an innovative and sustainable solution to address the dysfunctionality of the Tumán Food Market with the aim of promoting progress and comprehensive development of the city

Plan de mejora de la productividad en operaciones para la fabricación de bloques de concreto utilizando el estudio de métodos en la Municipalidad Distrital de Vice, 2022

El trabajo de investigación tiene como objetivo elaborar un Plan de mejora de la productividad de operaciones para la fabricación de bloques de concreto utilizando el Estudio de Métodos en la Municipalidad Distrital de Vice. Se siguió la metodología para el estudio de métodos empezando con la recolección de datos, analizados mediante el método del interrogatorio, para encontrar mejoras en las actividades. Se tomó como muestra las operaciones para la fabricación de bloquetas de concreto, y con la técnica de observación se registraron las operaciones que deben ser mejoradas. Como resultados se propuso extender los rieles para transporte de las tablas y evitar pérdidas de bloquetas, y en la curación de las mismas, ampliar el espacio de secado y de humectación colocando las tablas en andamios fabricados

GH-Deficient Survivors of Childhood Cancer: GH Replacement during Adult Life

Childhood survivors of cancer are prone to a number of adverse sequelae related to the therapeutic interventions undertaken to achieve remission. The endocrine system is frequently affected; hypothalamo-pituitary dysfunction, in particular GH deficiency, is common after cranial irradiation. It is unclear to what extent GH deficiency contributes to the abnormalities observed in adult survivors of childhood cancer, and whether GH replacement reverses these anomalies. We compared 27 GH-deficient survivors of childhood cancer with 27 adult age-and sex-matched controls and went on to replace GH in the patient group to determine whether GH resulted in improvements of the baseline abnormalities. The GH-deficient survivors of childhood cancer had an adverse lipid profile (total cholesterol, 5.4 vs. 4.6 mM, P ‫؍‬ 0.004; high-density lipoprotein cholesterol, 1.05 vs. 1.6 mM, P < 0.001; and triglycerides, 1.3 vs. 1.0 mM, P < 0.001) and were osteopenic (lumbar spine z-score, ؊1.53 vs. ؊0.31 SD score, P < 0.001; femoral neck z-score, ؊1.23 vs. ؊0.27 SD score, P ‫؍‬ 0.02); additionally, the female subgroup had an increased percentage body fat (43.6 vs. 32.8%, P ‫؍‬ 0.016). In keeping with the selection criterion, quality of life in the patient cohort, relative to the healthy controls, was severely impaired [adult GHdeficiency assessment (AGHDA), 15.5 (range, 8 -25) vs. 1 (range, 0 -19), P < 0.0001; psychological general well-being schedule, 67.5 (range, 18 -86) vs. 89.0 (range, 51-104), P < 0.0001]. After 12 months of GH replacement, small (but significant) improvements were observed in body composition in the male subgroup (waist-hip ratio, 0.871 vs. 0.863, P < 0.05); and in the female cohort, total cholesterol (6.0 vs. 5.2 mM, P ‫؍‬ 0.01) and triglyceride (2.1 vs. 1.4 mM, P ‫؍‬ 0.01) levels fell. Bone mineral density improved in only one of the four sites studied (ultradistal radius, ؊1.21 vs. ؊1.09, P ‫؍‬ 0.048) after a median duration of GH therapy of 18 months. Quality of life improved dramatically by 3 months (AGHDA, 15.5 vs. 10.0, P < 0.001), and the improvement was maintained at 12 months (AGHDA, 15.5 vs. 9.0, P < 0.001). Importantly, there was no clinical suggestion of tumor recurrence during the 12 months of GH replacement. The minor improvements observed in body composition, the lipid profile, and bone mineral density in GH-deficient adult survivors of childhood cancer after 12-18 months of physiological GH replacement suggest that GH deficiency may not be the major etiological factor in their pathogenesis; the converse seems to be true for the quality of life status of these individuals. We propose that, as in patients with hypopituitarism caused by pituitary disease, the main indication for GH replacement in GH-deficient survivors of childhood cancer should be severe impairment of quality of life. (J Clin Endocrinol Metab 87: 129 -135, 2002

Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case report

<p>Abstract</p> <p>Introduction</p> <p>Growth retardation is one of the cardinal manifestations of glycogen storage disease type Ia. It is unclear which component of the growth hormone and/or insulin-like growth factor axis is primarily disrupted, and management of growth impairment in these patients remains controversial. Here we report the first case in the literature where glycogen storage disease type Ia is associated with pituitary hypoplasia and growth hormone deficiency.</p> <p>Case presentation</p> <p>A 20-year-old woman with glycogen storage disease type Ia was admitted to our endocrinology department because of growth retardation. Basal and overnight growth hormone sampling at 2-hour intervals demonstrated low levels; however, provocative testing revealed a relatively normal growth hormone response. A hypoplastic anterior pituitary with preserved growth hormone response to provocative testing suggested the possibility of growth hormone neurosecretory dysfunction and/or primary pituitary involvement.</p> <p>Conclusion</p> <p>Pituitary hypoplasia may result from growth hormone-releasing hormone deficiency, a condition generally known as growth hormone neurosecretory dysfunction. It is an abnormality with a spontaneous and pulsatile secretion pattern, characterized by short stature, growth retardation and normal serum growth hormone response to provocative testing. However, in the case described in this report, a normal although relatively low growth hormone response during insulin tolerance testing and pituitary hypoplasia suggested that primary pituitary involvement or growth hormone neurosecretory dysfunction may occur in glycogen storage disease type Ia. This is a potential cause of growth failure associated with a lower somatotroph mass, and may explain the variable responsiveness to growth hormone replacement therapy in people with glycogen storage disease.</p

Modified-release hydrocortisone to provide circadian cortisol profiles

Context: Cortisol has a distinct circadian rhythm regulated by the brain's central pacemaker. Loss of this rhythm is associated with metabolic abnormalities, fatigue, and poor quality of life. Conventional glucocorticoid replacement cannot replicate this rhythm. Objectives: Our objectives were to define key variables of physiological cortisol rhythm, and by pharmacokinetic modeling test whether modified-release hydrocortisone (MR-HC) can provide circadian cortisol profiles. Setting: The study was performed at a Clinical Research Facility. Design and Methods: Using data from a cross-sectional study in healthy reference subjects (n = 33), we defined parameters for the cortisol rhythm. We then tested MR-HC against immediate-release hydrocortisone in healthy volunteers (n = 28) in an open-label, randomized, single-dose, cross-over study. We compared profiles with physiological cortisol levels, and modeled an optimal treatment regimen. Results: The key variables in the physiological cortisol profile included: peak 15.5 mu g/dl (95% reference range 11.7-20.6), acrophase 0832 h(95% confidence interval 0759-0905), nadir less than 2 mu g/dl (95% reference range 1.5-2.5), time of nadir 0018 h (95% confidence interval 2339-0058), and quiescent phase (below the mesor) 1943-0531 h. MR-HC 15 mg demonstrated delayed and sustained release with a mean (SEM) maximum observed concentration of 16.6 (1.4) mu g/dl at 7.41 (0.57) h after drug. Bioavailability of MR-HC 5, 10, and 15 mg was 100, 79, and 86% that of immediate-release hydrocortisone. Modeling suggested that MR-HC 15-20 mg at 2300 h and 10 mg at 0700 h could reproduce physiological cortisol levels. Conclusion: By defining circadian rhythms and using modern formulation technology, it is possible to allow a more physiological circadian replacement of cortisol. (J Clin Endocrinol Metab 94: 1548-1554, 2009

Evaluate the impact of dietary herbal appetizer on the growth performance of growth out common carp (Cyprinus carpio)

The main goal of the current study is to evaluate the impact of dietary herbal appetizer on the growth performance of growth out common carp. This project was conducted at Caspian sea research institute of ecology from 2013 to 2014. Totally 186 common carps with an average weight of 126.3 g were randomly distributed to 9 fiberglass tanks with area and depth of 16m2 and of 0.6 m. The experiment lasted for eight weeks and the fish were fed by three different diets as follows: 1. Commercial pellet contained no herbal additive (control diet) 2. Commercial pellet contained 1% herbal appetizer and 3. Commercial pellet contained 2% herbal appetizer. The results showed that common carp weight gains for diet 1 , 2 and 3 were 51.6, 49.3 and 57.6g respectively. The estimated growth rate was 39.03g for control diet, 40.03g for 1% inclusion of the additive and 48.65g for 2% inclusion of the additive. Results also showed that inclusion of the additive did not change statistically average final weight (p>0.05). A larger weight gain was observed at 2% additive inclusion although this was not statistically different with other treatments. In conclusion, with regard to the observed results, herbal appetizer administration cannot improve growth, feed conversion rate and weight gain in common carps

Pituitary insufficiency after operation of supratentorial intra- and extraaxial tumors outside of the sellar–parasellar region?

Recent studies investigating pituitary function after non-sellar brain tumor surgery showed that up to 38.2% of patients have pituitary insufficiency (PI). It has been assumed that the operation causes the PI, but preoperative hormone testing, which would have been necessary to prove this assumption, was not performed. The objective of this study is to answer the question if indeed microsurgery is the culprit of PI in patients with operatively treated non-sellar brain tumors. In this prospective trial, 54 patients with supratentorial non-sellar tumors were included. The basal levels of cortisol, prolactin, testosterone, estrogen, IGF-1, fT3, fT4, STH, TSH, ACTH, FSH, and LH were recorded preoperatively on days 1 and 7 after surgery. If basal hormone screening revealed an abnormality, a releasing hormone assay was performed. Before surgery, 24 of the 54 patients (44.4%) already had PI. Additional 25 patients showed either hypocortisolism or hypothyreoidism. As those patients had been pre-treated with dexamethasone and l-thyroxine, these findings were considered not to represent PI but drug effects. Hormone testing on days 1 and 7 after surgery revealed no changes. With 44.4% PI is a frequent finding in brain tumor patients already before surgery. The factors causing preoperative PI remain yet to be identified. The endocrine results after surgery are unchanged which rules out that surgery is the cause of PI

Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects

The adaptor protein-2 sigma subunit (AP2σ2) is pivotal for clathrin-mediated endocytosis of plasma membrane constituents such as the calcium-sensing receptor (CaSR). Mutations of the AP2σ2 Arg15 residue result in familial hypocalciuric hypercalcaemia type 3 (FHH3), a disorder of extracellular calcium (Ca(2+) o) homeostasis. To elucidate the role of AP2σ2 in Ca(2+) o regulation, we investigated 65 FHH probands, without other FHH-associated mutations, for AP2σ2 mutations, characterized their functional consequences and investigated the genetic mechanisms leading to FHH3. AP2σ2 mutations were identified in 17 probands, comprising 5 Arg15Cys, 4 Arg15His and 8 Arg15Leu mutations. A genotype-phenotype correlation was observed with the Arg15Leu mutation leading to marked hypercalcaemia. FHH3 probands harboured additional phenotypes such as cognitive dysfunction. All three FHH3-causing AP2σ2 mutations impaired CaSR signal transduction in a dominant-negative manner. Mutational bias was observed at the AP2σ2 Arg15 residue as other predicted missense substitutions (Arg15Gly, Arg15Pro and Arg15Ser), which also caused CaSR loss-of-function, were not detected in FHH probands, and these mutations were found to reduce the numbers of CaSR-expressing cells. FHH3 probands had significantly greater serum calcium (sCa) and magnesium (sMg) concentrations with reduced urinary calcium to creatinine clearance ratios (CCCR) in comparison with FHH1 probands with CaSR mutations, and a calculated index of sCa × sMg/100 × CCCR, which was ≥ 5.0, had a diagnostic sensitivity and specificity of 83 and 86%, respectively, for FHH3. Thus, our studies demonstrate AP2σ2 mutations to result in a more severe FHH phenotype with genotype-phenotype correlations, and a dominant-negative mechanism of action with mutational bias at the Arg15 residue